111, Inc. Announces $10 Million Share Repurchase Program!!!YI: 111, Inc. 2021-09-07 05:00:00 111, Inc. Announces $10 Million Share Repurchase ProgramLongby JetEquities111
YI: Bullish PennantBullish Pennant Pros: Descending volume during formation PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 7 250RSI above 50 Cons: 200MA flat Target: PT = 53.18$ Thank you to those who donate Coins! Stay Humble, have fun, make money! Longby LeLaf112
Immense volume traded at 23That's a massive volume shelf at 23. Keeping an eye on this. This ticker doesn't have options. by TroydTrades2
The explosive growth of E-Pharmacy in China We have already witnessed how e-commerce has taken the likes of Alibaba, JD.com, Pinduoduo, Baozun, etc registering strong growth over the past few years in China. This company, 1 Yaowang is serving a niche market unlike the big boys - Alibaba and JD.com in this e-pharmacy space in China. Read some articles here and here . I like its Q2 results and due to its small market cap, it is still not a favourite of the institutional players yet. You can see from chart that there is accumulation between price 5.60-8 dollars range for the last 8 months or so. I will be initiating a long position tonight. Longby dchua1969Updated 1
YI - Ascending TriangleWondering whether this is a bullish Ascending Triangle pattern setting up here and hence time to get long now on any break and then retest of triangle resistance/support?Longby nickatherton6
YI - Bullish Bounce - Can It Recover? RISKY..111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China. SHORT INTEREST 32.07K 08/15/19 P/E Current -1.99 P/E Ratio (with extraordinary items) -2.73 Average Recommendation: BUY Average Target Price: 98.42 (Most likely wrong)by DEXWireNews9
YI crab with MACD divergenceCrab looks to have reacted to the PRZ nicely. Also there is a divergence over the entire pattern. Expect price to climb a little higher.Longby UnknownUnicorn40417732
YIMy arrows are purely for educational and visual representation of how i would like the trade to play out for executions. I have no interested in continuing to sell the majors against the USD as we are already so low!! NASDAQ:YILongby CharlieRodriguezUpdated 0